NCT04260997

Effect of a Probiotic, Lactobacillus Gasseri BNR17, on Body Composition and Weight Management in Overweight Adults

A Randomised, Double-Blinded, Parallel, Placebo-Controlled Study Investigating the Effect of a Probiotic, Lactobacillus Gasseri BNR17, on Body Composition and Weight Management in Overweight Adults.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 125 (actual)
• Sponsor: UAS Labs LLC · Industry
• Sex: All
• Age: 25 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Lactobacillus gasseri BNR17™ has shown promise in several pre-clinical and randomized controlled clinical trials for weight management outcomes. The current randomized, double-blind, placebo-controlled, parallel-arm trial will further assess L. gasseri BNR17™ on body composition and weight management, and in a study population that is distinct to prior randomized controlled trials on the strain. The study will recruit 126 overweight adult participants who will be randomly assigned to consume L. gasseri BNR17™ or placebo once daily for 12 weeks.

Conditions

• Weight Management

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Lactobacillus gasseri BNR17™ capsule	Once per day (QD), 12 weeks
OTHER	Placebo capsule	Once per day (QD), 12 weeks

Timeline

• Start date: 2020-07-01
• Primary completion: 2021-05-01
• Completion: 2021-09-01
• First posted: 2020-02-07
• Last updated: 2021-09-29

Locations

1 site across 1 country: Ireland